Yongan Pharmaceutical (002365.SZ) released its performance for the first half of the year, with a net profit attributable to the parent company of 12.4957 million yuan, a year-on-year decrease of 76.19%.

Zhtng Cijng APP News, Yong'an Pharmaceutical (002365.SZ) released its 2025 interim report, during the reporting period, the company achieved operating income of 367 million yuan, a year-on-year decrease of 13.72%. The net profit attributable to the shareholders of the listed company was 12.4957 million yuan, a year-on-year decrease of 76.19%. The net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 2.2853 million yuan, a year-on-year decrease of 93.65%. Basic earnings per share were 0.0432 yuan.